For >20 years, our research center has conducted a multitude of clinical studies (+/-500 patients included) in several therapeutic areas but most specialized in CNS. 

Due to the expanded new facilities with day & night stay allowing intensive PK and other clinical assessments, including PSG, ARC has currently a Top Tier Clinical Study Program with 6 planned studies in 2019 with 2 Global, 2 American and 2 European Sponsors

  # Studies
Schizophrenia 4
Major Depression 6 (1 with PK) (+4 planned)
Cognitive impairment 1
Delirium/ Alzheimer 1
Obsessive –compulsive disorder 1
Primary insomnia 1 (with intensive PK)
Post-menopausal osteoporosis 1
Hypersomnia 1 (planned 2019)
ADHD 1 (planned 2019)
  # Studies
Phase II 4
Phase IIa-Biomarker/PK 4
Phase III 6
Phase III special protocol assistance 1